Surgical Closure of Patent Ductus Arteriosus in Premature Neonates Weighing Less Than 1,000 grams: Contemporary Outcomes

Abstract

Objective:

The safety of surgical closure of patent ductus arteriosus (PDA) in very low birth weight premature neonates has been questioned because of associated morbidities. However, these studies are vulnerable to significant bias as surgical ligation has historically been utilized as “rescue” therapy. The objective of this study was to review our institutions’ outcomes of surgical PDA ligation.

Methods:

All neonates with operative weight of ≤1.00 kg undergoing surgical PDA ligation from 2003 to 2015 were analyzed. Records were queried to identify surgical complications, perioperative morbidity, and mortality. Outcomes included pre- and postoperative ventilator requirements, pre- and postoperative inotropic support, acute kidney injury, surgical complications, and 30-day mortality.

Results:

One hundred sixty-six preterm neonates underwent surgical ligation. One hundred twenty-one (70.3%) had failed indomethacin closure. One hundred sixty-four (98.8%) patients required mechanical ventilation prior to surgery. At 17 postoperative days, freedom from the ventilator reached 50%. Of 109 (66.4%) patients requiring prolonged preoperative inotropic support, 59 (54.1%) were liberated from inotropes by postoperative day 1. Surgical morbidity was encountered in four neonates (2.4%): two (1.2%) patients had a postoperative pneumothorax requiring tube thoracostomy, one (0.6%) patient had a recurrent laryngeal nerve injury, and one (0.6%) patient had significant intraoperative bleeding. The 30-day all-cause mortality was 1.8% (n = 3); no deaths occurred intraoperatively.

Conclusion:

In this retrospective investigation, surgical PDA closure was associated with low 30-day mortality and minimal morbidity and resulted in rapid discontinuation of inotropic support and weaning from mechanical ventilation. Given the safety of this intervention, surgical PDA ligation merits consideration in the management strategy of the preterm neonate with a PDA.

Keywords

patent ductus arteriosus surgical ligation outcomes

Get full access to this article

View all access options for this article.

References

Benitz

. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatology. 2010;30(4):241–252.

Jhaveri

Moon-Grady

Clyman

. Early surgical ligation versus conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr. 2010;157(3):381–387.

Hamrick

Hansmann

. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125(5):1020–1030.

Bancalari

Clasure

Ganzalez

. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate. 2005;88(3):192–201.

Malviya

Ohlsson

Shah

. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013;(3):CD003951. doi:10.1002/14651858.CD003951.pub3.

Kaapa

Lanning

Koivisto

. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scan. 1983;72(2):179–184.

Cotton

Stahlman

Berder

Graham

Catteron

Kover

. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93(4):647–651.

Cassady

Crosue

Kirklin

. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 1989;320(23):1511–1516.

Weisz

McNamara

Shah

. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024–e1046.

10.

Chang

Chiu

Chen

Huang

Hsieh

. Surgical ligation of patent ductus arteriosus in very-low-birth-weight premature infants in the neonatal intensive care unit. J Fromos Med Assoc. 2009;108(1):69–71.